Note: Transcripts are generated using speech recognition software and may contain errors.
safety. Intolerable ity evaluations included extra parameters, symptoms, E. P s weight gain and Q T C interval. Both APP doses and 10 milligrams. **** produced a significant improvements from baseline in pans, total pans positive and significantly lower, C g I improvement scores, both app doses and how separated from placebo for Pan's total scores at Week two.